{"version":"1.0","provider_name":"Sickle Cell Disease Association of America Inc.","provider_url":"https:\/\/www.sicklecelldisease.org","author_name":"admin","author_url":"https:\/\/www.sicklecelldisease.org\/author\/admin\/","title":"Congressional Briefing on Progress in Sickle Cell Disease Treatment &amp; Policy Implications - Sickle Cell Disease Association of America Inc.","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"Xk23mZQgJR\"><a href=\"https:\/\/www.sicklecelldisease.org\/2019\/06\/12\/congressional-briefing-on-progress-in-sickle-cell-disease-treatment-policy-implications\/\">Congressional Briefing on Progress in Sickle Cell Disease Treatment &amp; Policy Implications<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.sicklecelldisease.org\/2019\/06\/12\/congressional-briefing-on-progress-in-sickle-cell-disease-treatment-policy-implications\/embed\/#?secret=Xk23mZQgJR\" width=\"600\" height=\"338\" title=\"&#8220;Congressional Briefing on Progress in Sickle Cell Disease Treatment &amp; Policy Implications&#8221; &#8212; Sickle Cell Disease Association of America Inc.\" data-secret=\"Xk23mZQgJR\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/www.sicklecelldisease.org\/wp-content\/uploads\/2019\/06\/capitol_hill_lg.jpg","thumbnail_width":500,"thumbnail_height":295,"description":"TUESDAY, JUNE 18, 2019 | 2:30 \u2013 3:30 PM DIRKSEN SENATE OFFICE BUILDING, ROOM G50 RSVP: Betsy Foss-Campbell, bfoss@asgct.org Join us for updates on Gene therapy approaches presented by\u00a0prominent scientists in the field How policymakers can support the development of\u00a0treatment options for sickle cell disease SPEAKERS Tim Scott, United States Senator Francesca Cook, MPH, Government [&hellip;]"}